| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794604 | Ophthalmology Retina | 2018 | 9 Pages |
Abstract
Combination intravitreal aflibercept and suprachoroidal CLS-TA is well tolerated and significantly reduces the need for additional intravitreal aflibercept injections over a 3-month period in patients with RVO. Preliminary evidence suggests that combination therapy may sustain edema resolution and improve visual outcomes.
Keywords
Hemiretinal vein occlusionHRVOIVTSD-OCTiOpRVOETDRSBRVOCRVOBCVACStstandard deviationBranch retinal vein occlusionRetinal vein occlusionCentral retinal vein occlusionbest-corrected visual acuityTriamcinolone acetonidestandard error of the meanintravitrealearly treatment diabetic retinopathy studycentral subfield thicknessVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Intraocular pressureSEM
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Peter A. MD, Charles C. MD, David M. MD, David S. MD, Mark MD, Donna MBE, Glenn PhD, Tanzanite Study Group Tanzanite Study Group,